MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 210 filers reported holding MEDICINES CO in Q2 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $36,622,000 | -93.4% | 431,152 | -96.1% | 0.01% | -93.6% |
| Q3 2019 | $553,392,000 | +38.4% | 11,067,825 | +1.0% | 0.12% | +42.0% |
| Q2 2019 | $399,715,000 | +38.9% | 10,960,086 | +6.5% | 0.09% | +35.4% |
| Q1 2019 | $287,670,000 | +45.9% | 10,292,310 | -0.1% | 0.06% | +32.7% |
| Q4 2018 | $197,186,000 | -36.0% | 10,302,328 | -0.0% | 0.05% | -24.6% |
| Q3 2018 | $308,159,000 | -18.4% | 10,302,858 | +0.2% | 0.06% | -22.6% |
| Q2 2018 | $377,442,000 | +11.8% | 10,284,536 | +0.4% | 0.08% | +10.5% |
| Q1 2018 | $337,476,000 | +21.1% | 10,245,172 | +0.5% | 0.08% | +22.6% |
| Q4 2017 | $278,624,000 | -25.9% | 10,191,102 | +0.4% | 0.06% | -27.9% |
| Q3 2017 | $376,141,000 | -2.0% | 10,154,995 | +0.6% | 0.09% | -4.4% |
| Q2 2017 | $383,777,000 | -21.4% | 10,096,752 | +1.2% | 0.09% | -23.7% |
| Q1 2017 | $488,113,000 | +45.2% | 9,981,861 | +0.8% | 0.12% | +40.5% |
| Q4 2016 | $336,102,000 | -9.8% | 9,902,860 | +0.3% | 0.08% | -9.7% |
| Q3 2016 | $372,517,000 | +13.0% | 9,870,604 | +0.7% | 0.09% | +9.4% |
| Q2 2016 | $329,722,000 | +6.5% | 9,804,398 | +0.7% | 0.08% | +4.9% |
| Q1 2016 | $309,474,000 | -14.7% | 9,741,054 | +0.2% | 0.08% | -14.7% |
| Q4 2015 | $362,841,000 | +2.4% | 9,717,183 | +4.1% | 0.10% | -4.0% |
| Q3 2015 | $354,324,000 | +33.7% | 9,334,149 | +0.8% | 0.10% | +45.6% |
| Q2 2015 | $265,056,000 | +3.0% | 9,264,412 | +0.9% | 0.07% | +3.0% |
| Q1 2015 | $257,299,000 | +3.1% | 9,182,673 | +1.8% | 0.07% | 0.0% |
| Q4 2014 | $249,503,000 | +22.7% | 9,017,091 | -1.0% | 0.07% | +17.9% |
| Q3 2014 | $203,338,000 | -22.5% | 9,110,108 | +0.9% | 0.06% | -21.1% |
| Q2 2014 | $262,394,000 | +2.1% | 9,029,419 | -0.2% | 0.07% | 0.0% |
| Q1 2014 | $257,027,000 | -25.5% | 9,043,874 | +1.2% | 0.07% | -28.3% |
| Q4 2013 | $345,122,000 | +19.3% | 8,936,354 | +3.6% | 0.10% | +8.8% |
| Q3 2013 | $289,243,000 | +64.2% | 8,629,000 | +50.7% | 0.09% | +59.6% |
| Q2 2013 | $176,105,000 | – | 5,725,145 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|